AJZ Engineering to re-equip Russian cancer centre:
This article was originally published in Clinica
Executive Summary
German company AJZ Engineering has been contracted to modernise and equip the "Blochin" Oncology Research Centre at the Russian Academy of Medical Sciences in Moscow. The contract is worth E60 million ($50 million) and involves re-equipping the surgery centre, the bone marrow transplant centre and the central sterilisation facility, and modernising parts of the centre's radiation therapy and laboratory diagnostic units. The project is expected to take two years. Jena-based AJZ Engineering will include a number of companies from eastern Germany in the project, mostly from Thuringia. The company co-operated with Siemens Medical Solutions to modernise the radiation therapy and imaging diagnostics units. AJZ Engineering is a joint venture of Analytik Jena and Carl Zeiss Jena.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.